Drug Type Small molecule drug |
Synonyms 무빙스탑츄어블정 |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (11 Dec 2025), |
Regulation- |
Molecular FormulaC17H28BrNO7 |
InChIKeyLACQPOBCQQPVIT-SEYKEWMNSA-N |
CAS Registry6533-68-2 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Motion Sickness | South Korea | 11 Dec 2025 |





